Atara Biotherapeutics
ATRA
$0.69
Share price
-2.35%
Change (1 day)
-66.99%
Change (1 year)
Categories
Operating Margin for Atara Biotherapeutics (ATRA)
Operating Margin as of May 2024 (TTM): -465.01%
According to Atara Biotherapeutics's latest financial reports and stock price the company's current Operating Margin is -465.01%. At the end of 2021 the company had an Operating Margin of -1,672.05%.
Operating Margin history for Atara Biotherapeutics from 2021 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -1,672.05% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ImmunoGen
IMGN | -203.81% | -56.17% | 🇺🇸 USA |
 Agenus
AGEN | -9.71% | -97.91% | 🇺🇸 USA |
 Affimed
AFMD | -210.66% | -54.70% | 🇩🇪 Germany |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.